Trial Profile
A Double-blind, Parallel Group, Randomised, Placebo Controlled, Multicenter, Bridging Study of Efficacy and Safety of KI1001 in the Improvement of Sleep Quality in ≥ 55 Years Old Insomnia Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Melatonin (Primary)
- Indications Insomnia
- Focus Registrational; Therapeutic Use
- Sponsors Kuhnil Pharmaceutical Company
- 24 Mar 2014 New trial record